Zdrowie i gospodarka · 31/03/2026
FDA Announces Decision on Hearing Request for TRADIPITANT Capsules Approval
The FDA has announced its decision on a request for a hearing regarding a proposal to refuse approval of a new drug application for TRADIPITANT capsules, submitted by Vanda Pharmaceuticals, Inc. for the treatment of gastroparesis symptoms.